Discontinuation report VIVAXIM
| Report ID | 161652 |
| Drug Identification Number | 02248361 |
| Brand name | VIVAXIM |
| Common or Proper name | Combined Purified Vi Polysaccharide Typhoid and Inactivated Hepatitis A Vaccine |
| Company Name | SANOFI PASTEUR LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Strength(s) | 160UNIT 25MCG |
| Dosage form(s) | SUSPENSION SOLUTION SUSPENSION SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1 x 1.0 mL (single dose) dual chamber syringe |
| Anatomical Therapeutical Chemical (ATC) code | J07CA |
| Anatomical Therapeutical Chemical (ATC) description | BACTERIAL AND VIRAL VACCINES, COMBINED |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2022-05-31 |
| Remaining supply date | 2022-05-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | No supply remaining |
| Company comments | Discontinuation of the manufacturing of this product. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-06-01 | French | Compare |
| v3 | 2022-06-01 | English | Compare |
| v2 | 2022-06-01 | English | Compare |
| v1 | 2022-06-01 | English | Compare |
Showing 1 to 4 of 4